Oncopeptides AB (0RN4)
Market Closed
12 Dec, 15:30
LSE 
kr
5. 21
-0.14
-2.66%
kr
154.35M Market Cap
- P/E Ratio
0% Div Yield
132,672 Volume
0 Eps
kr 5.36
Previous Close Day Range
5.21 5.33
Year Range
1.29 6.5
Want to track 0RN4 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 67 days
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| OND OND Oncopeptides AB 19 Feb 2026 (In 2 months) | | - | - |
| OND OND Oncopeptides AB 5 Nov 2025 | | - | - |
| OND OND Oncopeptides AB 21 Aug 2025 | | - | - |
| OND OND Oncopeptides AB 8 May 2025 | | - | - |
| OND OND Oncopeptides AB 25 Feb 2025 | | - | - |
| OND OND Oncopeptides AB 7 Nov 2024 | | - | - |
| OND OND Oncopeptides AB 14 Aug 2024 | | - | - |
| OND OND Oncopeptides AB 31 May 2024 | | - | - |
0RN4 Earnings Reports FAQ
What is the earnings per share (EPS) for 0RN4?
The current EPS is 0.
What is the company's earnings growth rate?
Oncopeptides AB has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Oncopeptides AB has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Oncopeptides AB are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 0RN4 at this time, as Oncopeptides AB has no recent EPS data to calculate it.
2025 © Marketlog. All Rights Reserved.
